News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
3,854 Results
Type
Article (234)
Company Profile (1)
Press Release (3619)
Section
Business (838)
Career Advice (12)
Deals (142)
Drug Delivery (1)
Drug Development (872)
FDA (171)
Job Trends (269)
News (2003)
Policy (202)
Tag
Academia (7)
Alliances (162)
ALS (2)
Alzheimer's disease (1)
Antibody-drug conjugate (ADC) (1)
Approvals (179)
Artificial intelligence (3)
Autoimmune disease (20)
Bankruptcy (1)
Best Places to Work (282)
Biotechnology (1)
Bladder cancer (11)
Breast cancer (1)
Cancer (53)
Cardiovascular disease (35)
Career advice (10)
CAR-T (11)
Cell therapy (20)
Clinical research (862)
Collaboration (12)
Compensation (27)
Complete response letters (5)
COVID-19 (5)
CRISPR (6)
C-suite (7)
Data (121)
Diabetes (2)
Diagnostics (8)
Drug discovery (1)
Drug pricing (1)
Duchenne muscular dystrophy (35)
Earnings (513)
Events (671)
Executive appointments (7)
FDA (227)
Funding (10)
Gene editing (8)
Gene therapy (25)
GLP-1 (15)
Government (27)
Guidances (6)
Healthcare (62)
IgA nephropathy (2)
Immunology and inflammation (10)
Immuno-oncology (1)
Infectious disease (5)
Intellectual property (1)
Interviews (2)
IPO (99)
Job creations (8)
Job search strategy (9)
JPM (1)
Layoffs (3)
Legal (7)
Liver cancer (4)
Lung cancer (8)
Lymphoma (4)
Manufacturing (6)
Medical device (66)
Medtech (67)
Mergers & acquisitions (46)
Metabolic disorders (22)
mRNA (1)
Multiple sclerosis (1)
Neurodegenerative disease (4)
Neuropsychiatric disorders (2)
Neuroscience (16)
NextGen: Class of 2026 (21)
Non-profit (10)
Obesity (19)
Opinion (1)
Patents (1)
Patient recruitment (5)
People (239)
Phase 1 (197)
Phase 2 (357)
Phase 3 (423)
Pipeline (121)
Postmarket research (9)
Preclinical (52)
Radiopharmaceuticals (3)
Rare diseases (23)
Real estate (6)
Regulatory (233)
Research institute (5)
Resumes & cover letters (3)
Schizophrenia (1)
Series A (1)
Series B (2)
Spinal muscular atrophy (37)
Startups (24)
Venture capital (1)
Weight loss (9)
Date
Today (2)
Last 7 days (4)
Last 30 days (24)
Last 365 days (356)
2026 (97)
2025 (369)
2024 (386)
2023 (392)
2022 (376)
2021 (351)
2020 (367)
2019 (296)
2018 (243)
2017 (181)
2016 (93)
2015 (136)
2014 (124)
2013 (64)
2012 (48)
2011 (45)
2010 (40)
Location
Asia (106)
Australia (10)
California (181)
Canada (44)
China (9)
Colorado (36)
Connecticut (9)
Delaware (14)
Europe (264)
Florida (13)
Georgia (2)
Illinois (1)
India (2)
Japan (8)
Louisiana (1)
Maryland (8)
Massachusetts (143)
Minnesota (1)
New Jersey (49)
New York (18)
North Carolina (7)
Northern California (155)
Ohio (2)
Pennsylvania (43)
South America (1)
Southern California (20)
Texas (15)
United States (530)
Washington State (5)
3,854 Results for "myos".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cook MyoSite and Veristat Partner in Complex, Phase III, Adaptive Clinical Study of Investigational Cell Therapy for Unmet Need in Women’s Health
September 16, 2025
·
3 min read
Pharm Country
MYOS CORP, Formerly Known as Myos Rens Technology, Inc., Issues Notice to its Shareholders
MYOS CORP (“MYOS” or the “Company”), is a research-based advanced nutrition company with divisions that address both Human Nutrition and Animal Health . MYOS is the sole owner of Fortetropin ® , a proprietary advanced nutrition product developed and owned by MYOS, that has been shown in multiple veterinary and human cli
December 15, 2020
·
4 min read
Gynov Uses Myo-Inositol to Combat Both Male and Female Infertility
Infertility Is a Common Struggle for Both Sexes. The Innovative French Health Brand Gynov Is Addressing This Concern with Myo-Inositol.
February 21, 2022
·
3 min read
Press Releases
HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
March 16, 2026
·
6 min read
Cardiovascular disease
Cytokinetics’ Moment of Truth: Can Aficamten Take On BMS in Hypertrophic Cardiomyopathy?
After 27 years in business, Cytokinetics hopes to pit its own cardiac myosin inhibitor against one it initially developed—now owned by Bristol Myers Squibb—in a market worth billions. Aficamten has a PDUFA date of Dec. 26.
December 19, 2025
·
5 min read
·
Dan Samorodnitsky
Press Releases
Lipella Pharmaceuticals Re-signs Manufacturing Collaboration Agreement with Cook MyoSite to Support LP-310 Clinical Development
June 4, 2025
·
4 min read
Press Releases
NorthStrive Biosciences Announces U.S. Arrival of EL-32 Working Cell Bank and Initiation of Manufacturing Optimization for Dual Myostatin Assets Targeting Muscle Preservation with GLP-1 Therapies in Collaboration with Modulant Biosciences
April 13, 2026
·
4 min read
Press Releases
University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center
February 5, 2026
·
4 min read
Press Releases
Curi Bio and Cook MyoSite Announce Strategic Partnership
April 30, 2025
·
3 min read
Press Releases
Alzamend Neuro Reports Encouraging Pharmacodynamic Data from Phase II Clinical Trial of AL001 “Lithium in Brain” Study in a Trial Conducted at Massachusetts General Hospital
April 7, 2026
·
8 min read
1 of 386
Next
